Page last updated: 2024-10-23

5-methoxypsoralen and Eczema, Atopic

5-methoxypsoralen has been researched along with Eczema, Atopic in 2 studies

5-Methoxypsoralen: A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS.
5-methoxypsoralen : A 5-methoxyfurocoumarin that is psoralen substituted by a methoxy group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tzaneva, S1
Kittler, H1
Holzer, G1
Reljic, D1
Weber, M1
Hönigsmann, H1
Tanew, A1

Trials

1 trial available for 5-methoxypsoralen and Eczema, Atopic

ArticleYear
5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: a randomized crossover trial.
    The British journal of dermatology, 2010, Volume: 162, Issue:3

    Topics: 5-Methoxypsoralen; Adolescent; Adult; Cross-Over Studies; Dermatitis, Atopic; Female; Humans; Male;

2010

Other Studies

1 other study available for 5-methoxypsoralen and Eczema, Atopic

ArticleYear
British Photodermatology Group guidelines for PUVA.
    The British journal of dermatology, 1994, Volume: 130, Issue:2

    Topics: 5-Methoxypsoralen; Cataract; Dermatitis, Atopic; Humans; Methoxsalen; Mycosis Fungoides; Psoriasis;

1994